COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,884 Articles (22,568 medRxiv, 8,316 bioRxiv)

Most recent first Previous |  Page 2291: Articles 22901-22910  | Next

SARS-CoV-2 infection and transmission in educational settings: cross-sectional analysis of clusters and outbreaks in England
Ismail, S. A., Saliba, V., Lopez Bernal, J. A., Ramsay, M. E., Ladhani, S. N.
10.1101/2020.08.21.20178574 — Posted: 2020-08-24 Discussion: Onsite
Health Disparities and COVID-19: A Retrospective Study Examining Individual and Community Factors Causing Disproportionate COVID-19 Outcomes in Cook County, Illinois, March 16-May 31, 2020
Unruh, L., Dharmapuri, S., Yinglin, X., Soyemi, K.
10.1101/2020.08.21.20179317 — Posted: 2020-08-24 Discussion: Offsite
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Tani, H., Tan, L., Kimura, M., Yoshida, Y., Yamada, H., Fukushi, S., Saijo, M., Kawasuji, H., Ueno, A., Miyajima, Y., Fukui, Y., Sakamaki, I., Yamamoto, Y., Morinaga, Y.
10.1101/2020.08.21.262295 — Posted: 2020-08-23
Lipid droplets fuels SARS-CoV-2 replication and inflammatory response
Gomes Dias, S. S., Cardoso, V. S., Ferreira, A. C., Sacramento, C. Q., Fintelman-Rodrigues, N., Temerozo, J. R., Teixeira, L., Barreto, E. A., Mattos, M., de Freitas, C. S., Azevedo-Quintanilha, I., Manso, P. P. A., Hottz, E. D., Pao, C. R. R., Bou-Habib, D. C., Bozza, F. A., Souza, T. M. L., Bozza, P. T.
10.1101/2020.08.22.262733 — Posted: 2020-08-23
Impact of Duration of Cessation of Mass BCG Vaccination Programs on Covid -19 Mortality
Raham, T. F.
10.1101/2020.08.20.20178889 — Posted: 2020-08-23
Poor knowledge of COVID-19 and unfavourable perception of the response to the pandemic by healthcare workers at the Bafoussam Regional Hospital (West Region - Cameroon)
FOUOGUE, J. T., NOUBOM, M., KENFACK, B., DONGMO, N. T., TABEU, M., MEGOZEU, L., ALIMA, J. M., FOGANG, Y. F., RIM, L. C. A. N., FOUELIFACK, F. Y., FOUEDJIO, J. H., MANEBOU, P. L. N. F., ZE, C. D. B., KOUAM, B. F., FOMETE, L. N., TEBEU, P. M., KEMFANG, J. D. N., FOUMANE, P., SANDO, Z., OROCK, G. E. E.
10.1101/2020.08.20.20178970 — Posted: 2020-08-23
COVID-19 Risk Perception Among U.S. Adults: Changes from February to May 2020
Malik, A. A., McFadden, S. M., Elharake, J. A., Aguolu, O. G., Shafiq, M., Omer, S. B.
10.1101/2020.08.20.20178822 — Posted: 2020-08-23
Dynamic causal modeling of the COVID-19 pandemic in northern Italy predicts possible scenarios for the second wave
Gandolfi, D., Pagnoni, G., Filippini, T., Goffi, A., Vinceti, M., D'Angelo, E. U., Mapelli, J.
10.1101/2020.08.20.20178798 — Posted: 2020-08-23
COVID-19 in a cohort of pregnant women and their descendants. Cohort profile in the MOACC-19 study
Llorca, J., Lechosa-Muniz, C., Gortazar, P., Fernandez-Ortiz, M., Jubete, Y., Cabero-Perez, M. J.
10.1101/2020.08.20.20178657 — Posted: 2020-08-23
Estimation of case-fatality rate in COVID-19 patients with hypertension and diabetes mellitus in the New York State
Ge, Y., Sun, S., Shen, Y.
10.1101/2020.08.20.20178962 — Posted: 2020-08-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).